USA Financial Formulas’s Hims & Hers Health HIMS Stock Holding History

USA Financial Formulas’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13	Closed	-$422	–	477
2025 Q4	$422	Buy	+13	New	+$557	﹤0.01%	403

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Defiance ETFs New York $7.37B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

USA Financial Formulas's HIMS Position: Q1 2026 in Review

USA Financial Formulas sold out of Hims & Hers Health (HIMS) in Q1 2026, closing a stake of 13 shares — an estimated $422 sold.

USA Financial Formulas first reported a position in HIMS in Q4 2025 and held it in 1 quarter. The position peaked at $422 in Q4 2025. 436 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

USA Financial Formulas reported no remaining Hims & Hers Health position as of Q1 2026 after selling out during the quarter.
USA Financial Formulas sold 13 Hims & Hers Health shares in Q1 2026, an estimated $422.
USA Financial Formulas first reported a position in Hims & Hers Health in Q4 2025 and held it in 1 quarter.
USA Financial Formulas's Hims & Hers Health position peaked at $422 in Q4 2025.
436 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on USA Financial Formulas's 13F filing for Q1 2026, filed 14 Apr 2026.